Possible structuro-functional association of pyracetam and vasopressin

T. A. Gudasheva, R. U. Ostrovskaya, S. S. Trofimov, et al., Khim.-farm. Zh., No. 11, 1322–1329 (1985). M. D. Mashkovskii, L. F. Roshchina, and A. I. Polezhaeva, Farmakol. Toksikol., No. 6, 676–683 (1977). Great Britain Patent No. 1503680 (1978). B. Bering, W. E. Müller, Arzneim. Forsch.,35(II), No. 9, 1350–1352 (1985). J. P. H. Burbach, G. L. Kovacs, and D. De Wied, Science,221, No. 4617, 1310–1312 (1983). J. Bures and O. Buresova, J. Comp. Physiol. Psychol.,56, 268–272 (1963). C. E. Giurgea and F. E. Moyersoons, Arch. Int. Pharmacodyn.,199, No. 1, 67–78 (1972). G. L. Kovács, H. D. Veldhuis, D. H. G. Versteeg, and D. DeWied, Brain Res.,371, No. 1, 17–24 (1986). F. E. Moyersons, C. E. Giurgea, and A. C. Evraerd, Arch. Int. Pharmacodyn.,166, No. 1, 238–251 (1967). J. P. Pede, L. Schimpfessel, and R. Crokaert, Farm. Tijdschr. Belg.,50, No. 4, 298–306 (1973). X.-Ch. Wang and J. P. H. Burbach, FEBS Lett.,197, No. 1, 164–168 (1986).